Tackling clinical trials disparities in Africa
DOI:
https://doi.org/10.7196/SAMJ.2025.v116i3.4479Keywords:
clinical trials, cancer, AfricaAbstract
-
References
1. Casolino R, Tatah L, Charnaud S, Santero M, Ilbawi A, Ross AL. The WHO global landscape of cancer clinical trials. Nature Med 2025;31(9):2901-2912. https://doi.org/10.1038/s41591-025-03926-x
2. Sharma R, Aashima, Nandaet M, al. Mapping cancer in Africa: A comprehensive and comparable characterization of 34 cancer types using estimates from GLOBOCAN 2020. Front Public Health 2022;10:839835. https://doi.org/10.3389/fpubh.2022.839835
3. Saleh M, Sharma K, Shamshudin A, Obayo I, Gondi S, Karimi N. Regulatory approval of clinical trials: Is it time to reinvent the wheel? BMJ Glob Health 2024;9(1):e013727. https://doi.org/10.1136/ bmjgh-2023-013727
4. Mankan AK, Shankar A, Limayeet S, et al. Cancer trials ecosystem in India – ready for prime time? JCO Glob Oncol 2024;10:e2300405. https://doi.org/10.1200/go.23.00405
5. Science for Africa Foundation. Clinical Research and Trials Community (CRTC). Nairobi: SFA Foundation, 2026. https://scienceforafrica.foundation/clinical-research-and-trials-community (accessed 16 March 2026).
6. World Health Organization. A heavy burden: The productivity cost of illness in Africa. Geneva: WHO, 2019. https://www.afro.who.int/publications/heavy-burden-productivity-cost-illness-africa
Downloads
Published
Issue
Section
License
Copyright (c) 2026 M Kaur
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
